Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


MorphoSys, Incyte Announce First Patient Dosed In Phase 3 InMIND Study


RTTNews | Apr 19, 2021 04:21PM EDT

16:21 Monday, April 19, 2021 (RTTNews.com) - MorphoSys, Incyte Announce First Patient Dosed In Phase 3 InMIND Study

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC